Connect with us

Hi, what are you looking for?

Friday, Dec 3, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Khiron opens its first medical cannabis clinic in Europe

The company says it will use data from its clinics in Colombia and Peru to help treat patients in the UK

The new clinic location will be in the district of Chelsea. Photo by Mark Ahsmann via Wikimedia Commons

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) has opened its first medical cannabis clinic in Europe, where it will use data compiled from over 10,000 patients treated with cannabis at its Latin American locations.

On Wednesday, the Toronto-based cannabis company, with primary operations in Colombia, said it launched the clinic under its Zerenia banner in the Chelsea district of London, U.K.

During the initial stage of operations, the clinic will focus on pain management and later expand treatment to other medical fields such as mental health, women’s health, oncology and neurology.

The hybrid clinic will provide personalized cannabinoid-based therapies in person and via video consultations to increase accessibility to patients across the U.K.

Healthcare professionals at the clinic will be certified and receive medical training via the Khiron Academy digital education platform.

With the new location, Khiron will now own 15 medical cannabis clinics in Colombia, Peru and the U.K.

“This is a great milestone for Khiron and will contribute significantly to the dynamics of developing a market for medical cannabis in the U.K.,” company president Franziska Katterbach said in a statement.

“From day one, it has been our goal to improve patient access to medical cannabis where suitable and also create evidence for the effectiveness and tolerability of medical cannabis; opening a U.K. cannabis clinic is just another logical step to serve patients’ and clinicians needs.”

Read more: 80% of patients report reduced symptoms after using cannabis oil: Khiron study

Read more: Cannabis helps manage painful endometriosis symptoms: study

In March, Khiron opened three more of its Zerenia clinics in Bogota, Cali and Bucaramanga. Image via Khiron

The opening of the clinic will strengthen Khiron’s sales in Europe, which accounted for 30 per cent of its total medical cannabis revenues in the third fiscal quarter this year.

Khiron first entered the U.K. in 2019 by becoming a founding member and the Latin American supplier for Project Twenty21, which offers low prices for patients having difficulty accessing the market.

While Germany dominates for now, Prohibition Partners expects the U.K.’s medical cannabis market will be the fastest growing in Europe by 2025.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

natalia@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe